Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts

Vox Sanguinis

Volumn 99, Issue 4, 2010, Pages 348-353

  Giers, Günther ^a   Wenzel, F ^a   Riethmacher, R ^a   Lorenz, H ^b   Tutschek, B ^c,d  

^a Clinical Hemostaseology and Transfusion Medicine   (Germany)

^b Biometry and Statistics ^*  (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Foetal alloimmune thrombocytopenia; Foetal IgG infusion; Intrauterine therapy

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ARTICLE; CLINICAL ARTICLE; CORDOCENTESIS; FEMALE; GESTATIONAL AGE; HUMAN; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; BLOOD PLATELETS; FEMALE; FETAL DISEASES; FETAL THERAPIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; PLATELET COUNT; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 77958513987     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01367.x     Document Type: Article

References (46)

1. Bussel JB, Zabusky MR, Berkowitz RL, et al.: Fetal alloimmune thrombocytopenia, N Engl J Med, 1997; 337:22-26
2. Giovangrandi Y, Daffos F, Kaplan C, et al.: Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia, Lancet, 1990; 336:310
3. Overton TG, Duncan KR, Jolly M, et al.: Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome, Am J Obstet Gynecol, 2002; 186:826-831
4. Berkowitz RL, Lesser ML, McFarland JG, et al.: Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial, Obstet Gynecol, 2007; 110:249-255
5. Bussel JB, Berkowitz RL, Lynch L, et al.: Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin, Am J Obstet Gynecol, 1996; 174:1414-1423
6. Bussel JB, Berkowitz RL, McFarland JG, et al.: Antenatal treatment of neonatal alloimmune thrombocytopenia, N Engl J Med, 1988; 319:1374-1378
7. Daffos F, Forestier F, Muller JY, et al.: Prenatal treatment of alloimmune thrombocytopenia, Lancet, 1984; 2:632
8. Engelfriet CP, Reesink HW, Kroll H, et al.: Prenatal management of alloimmune thrombocytopenia of the fetus, Vox Sang, 2003; 84:142-149
9. Gaddipati S, Berkowitz RL, Lembet AA, et al.: Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility, Am J Obstet Gynecol, 2001; 185:976-980
10. Lynch L, Bussel JB, McFarland JG, et al.: Antenatal treatment of alloimmune thrombocytopenia, Obstet Gynecol, 1992; 80:67-71
11. Massey GV, McWilliams NB, Mueller DG, et al.: Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopenia, J Pediatr, 1987; 111:133-135
12. Porcelijn L, Van den Akker ES, Oepkes D: Fetal thrombocytopenia, Semin Fetal Neonatal Med, 2008; 13:223-230
13. Reesink HW, Engelfriet CP, Giers G, et al.: Prenatal management of fetal alloimmune thrombocytopenia, Vox Sang, 1993; 65:180-189
14. Sidiropoulos D, Straume B: The treatment of neonatal isoimmune thrombocytopenia with intravenous immunoglobin (IgG i.v.), Blut, 1984; 48:383-386
15. Suarez CR, Anderson C: High-dose intravenous gammaglobulin (IVG) in neonatal immune thrombocytopenia, Am J Hematol, 1987; 26:247-253
16. Kaplan C: Foetal and neonatal alloimmune thrombocytopaenia, Orphanet J Rare Dis, 2006; 1:39
17. Berkowitz RL, Bussel JB, McFarland JG: Alloimmune thrombocytopenia: state of the art 2006, Am J Obstet Gynecol, 2006; 195:907-913
18. Murphy MF, Bussel JB: Advances in the management of alloimmune thrombocytopenia, Br J Haematol, 2006; 136:366-378
19. Van Den Akker ES, Oepkes D: Fetal and neonatal alloimmune thrombocytopenia, Best Pract Res Clin Obstet Gynaecol, 2008; 22:3-14
20. Van Den Akker ES, Oepkes D, Lopriore E, et al.: Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective, BJOG, 2007; 114:469-473
21. Giers G, Wenzel F, Stockschläder M, et al.: Fetal alloimmune thrombocytopenia and maternal i.v. IgG infusions. Haematologica, 2010; doi:
22. Kaplan C, Murphy MF, Kroll H, et al.: Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids - more questions than answers. European Working Group on FMAIT, Br J Haematol, 1998; 100:62-65
23. Kroll H, Kiefel V, Giers G, et al.: Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia, Transfus Med, 1994; 4:293-296
24. Marzusch K, Schnaidt M, Dietl J, et al.: High-dose immunoglobulin in the antenatal treatment of neonatal alloimmune thrombocytopenia: case report and review, Br J Obstet Gynaecol, 1992; 99:260-262
25. Mir N, Samson D, House MJ, et al.: Failure of antenatal high-dose immunoglobulin to improve fetal platelet count in neonatal allo-immune thrombocytopenia, Vox Sang, 1988; 55:188-189
26. Nicolini U, Tannirandorn Y, Gonzalez P, et al.: Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia, Am J Obstet Gynecol, 1990; 163:1144-1146
27. Wenstrom KD, Weiner CP, Williamson RA: Antenatal treatment of fetal alloimmune thrombocytopenia, Obstet Gynecol, 1992; 80:433-435
28. Kiefel V, Santoso S, Weisheit M, et al.: Monoclonal antibody - specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies, Blood, 1987; 70:1722-1726
29. Forestier F, Cox WL, Daffos F, et al.: The assessment of fetal blood samples, Am J Obstet Gynecol, 1988; 158:1184-1188
30. Kleihauer E, Braun H, Betke K: [Demonstration of fetal hemoglobin in erythrocytes of a blood smear.], Klin Wochenschr, 1957; 35:637-638
31. Hadlock FP, Harrist RB, Sharman RS, et al.: Estimation of fetal weight with the use of head, body, and femur measurements - a prospective study, Am J Obstet Gynecol, 1985; 151:333-337
32. Giers G: Pathopysiologie, Diagnostik und Therapie von Immunthrombozytopenien in der Schwangerschaft. Germany, Habilitationschrift der Hohen Medizinischen Fakultät der Heinrich-Heine-Universität Düsseldorf, 1999
33. Haemonetics: Haemonetics® MCS + ArtNr 09000-220E/ED, Thrombozytenprotokoll, Bedienungsanleitung, Rev.A 1997. 1997: 1-68
34. Giers G, Wenzel F, Fischer J, et al.: Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia, Vox Sang, 2010; 98:423-430
35. Diggle PJ, Heagerty P, Liang KY, et al.: Analysis of Longitudinal Data. Oxford, Statistical Science Series 25, 2005: 54-80, 288-95
36. Molenberghs G, Thijs H, Jansen I, et al.: Analyzing incomplete longitudinal clinical trial data, Biostatistics, 2004; 5:445-464
37. Molenberghs GK, Kenward MG: Missing Data in Clinical trials. John Wiley and Sons Ltd, Chichester, UK. 2007: 41-66
38. SAS Institute Inc: Statistical Software (proC MIXED, PHREG) Vers. 9.1. Cary, NC, USA, SAS Institute Inc, 2007
39. Zotz RB, Giers G, Maruhn-Debowski B, et al.: Genetic typing of human platelet antigen 1 (HPA-1) by oligonucleotide ligation assay in a specific and reliable semi-automated system, Br J Haematol, 1997; 96:198-203
40. Arnold DM, Smith JW, Kelton JG: Diagnosis and management of neonatal alloimmune thrombocytopenia, Transfus Med Rev, 2008; 22:255-267
41. Bussel JB, Zacharoulis S, Kramer K, et al.: Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia, Pediatr Blood Cancer, 2005; 45:176-183
42. Dreyfus M, Kaplan C, Verdy E, et al.: Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group, Blood, 1997; 89:4402-4406
43. Mueller-Eckhardt C, Kiefel V, Grubert A, et al.: 348 cases of suspected neonatal alloimmune thrombocytopenia, Lancet, 1989; 1:363-366
44. Berkowitz RL, Kolb EA, McFarland JG, et al.: Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia, Obstet Gynecol, 2006; 107:91-96
45. Birchall JE, Murphy MF, Kaplan C, et al.: European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia, Br J Haematol, 2003; 122:275-288
46. Killie MK, Husebekk A, Kjeldsen-Kragh J, et al.: A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn, Haematologica, 2008; 93:870-877